📰 Oceanpine Capital News

Oceanpine Capital News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Oceanpine Capital. Real-time updates on events, politics, business and more.

Tencent, Guoxin co-lead $97m Series E round in Chinese biopharma Evopoint

February 21, 2024

Tencent Investment and Guoxin Investment have jointly led a Series E funding round of 700 million yuan ($97.4 million) in Evopoint Biosciences.

Evopoint Biosciences Jinan Industrial Development Investment Group Tencent Investment Guoxin Investment Yuekai Securitie Yuekai Capital Investment

Source: dealstreetasia.com

YS Biopharma : Change of Independent Director - Form 6-K -December 12, 2023 at 06:40 am EST

December 12, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER ...

Yi Zhang United States Yuan Liu Gang Li Chunyuan Wu Rodman Renshaw

Source: marketscreener.com

Editor's take: The week that was — May 29-June 3

June 4, 2023

Atleast three Indian startups—BYJU’S, NestAway, and Meesho—saw deep cuts in their valuations this week.

Hong Kong Nova Scotia Dave Richards Jo Huang Chris Freund Joseph Aditya

Source: dealstreetasia.com

Asia-Pacific technology industry venture financing deals Q3 2022

January 18, 2023

The top five technology industry venture financing deals in Asia-Pacific in Q3 2022 - GlobalData Deals Database

China General Qinghai Lihao Semiconductor Materials Sesame Intelligent Technology Guangdong Weirong Electronic Technology Industrial Bank Yangzijiang Financial Holding

Source: verdict.co.uk

China's Lihao raises $307m Series B round to speed up chip R&D, build new facilities

September 27, 2022

It claims to have reached unicorn status less than 18 months since its inception in April 2021

Xue Ling China Us Green Fund Cv Fund Zhejiang United Investment Group Belgium Direct Equity Investment Fund China Lihao Semiconductor

Source: dealstreetasia.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Inspirna, Inc.: Inspirna to Present Phase 1b RGX-202-01 Clinical Trial Data at the 2022 ESMO World Congress on Gastrointestinal Cancer

June 28, 2022

Favorable efficacy and safety support further development of RGX-202-01 in advanced or metastatic second-line colorectal cancer Inspirna, Inc., a clinical stage biopharmaceutical company developing

New York United States Al Iskandariyah Rockefeller University Comunidad Autonoma De Cataluna Kostenloser Wertpapierhandel

Source: finanznachrichten.de

Inspirna to Present Phase 1b RGX-202-01 Clinical Trial Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

May 27, 2022

Press release content from Business Wire. The AP news staff was not involved in its creation.

New York United States Al Iskandariyah Rockefeller University Masoud Tavazoie Maeve Conneighton

Source: apnews.com

Inspirna to Present at 21st Annual Needham Virtual Healthcare Conference

April 7, 2022

NEW YORK--(BUSINESS WIRE)--Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and biologic cancer therapeutics, announced today that CEO Masoud Tavazoie, M.D., Ph.D., will present at the 21st Annual Needham Virtual Healthcare Conference at 10:15 A.M. EST on April 14,...

New York United States Al Iskandariyah Rockefeller University Masoud Tavazoie Maeve Conneighton

Source: pharmiweb.com